Weight Loss with Hypophosphatasia: A South African Guide
Hypophosphatasia (HPP) is a rare inherited metabolic disorder caused by mutations in the ALPL gene, which encodes tissue-nonspecific alkaline phosphatase (TNSALP). This enzyme is essential for bone mineralisation, and its deficiency leads to a spectrum of disease ranging from stillbirth with unmineralised bone to mild adult forms with stress fractures, dental anomalies, and muscle weakness. Managing weight with HPP requires careful navigation of bone fragility, vitamin B6 toxicity risks from supplements, and the exercise limitations imposed by fracture-prone bones — all within a South African context where access to the enzyme replacement therapy asfotase alfa (Strensiq) remains limited and costly.
Understanding Hypophosphatasia
The ALPL gene (chromosome 1p36.12) encodes TNSALP, which is expressed on the outer cell membrane of osteoblasts, hepatocytes, and kidney cells. TNSALP's job is to cleave inorganic pyrophosphate (PPi), a potent inhibitor of hydroxyapatite crystal formation. Without TNSALP, PPi accumulates, blocking mineralisation — bones and teeth fail to harden properly.
HPP is classified by age of onset and severity:
- Perinatal lethal form — severe, incompatible with life; stillbirth or neonatal death
- Infantile form — rickets-like presentation before 6 months; life-threatening respiratory failure from soft ribs
- Childhood form (juvenile HPP) — premature loss of baby teeth (before age 5, with intact root), rickets, short stature, stress fractures
- Adult form — stress fractures (especially metatarsals and femur), chondrocalcinosis, pseudogout, muscle weakness, dental disease; often diagnosed late in life
- Odontohypophosphatasia — isolated dental manifestation only (premature tooth loss)
Inheritance is autosomal recessive for severe forms; autosomal dominant (with variable penetrance) for milder adult and odontohypophosphatasia forms. Prevalence of severe HPP is approximately 1 in 100,000 births; mild forms may be considerably more common but underdiagnosed.
Why Weight Matters in HPP
Excess body weight in HPP creates a directly dangerous mechanical problem: every kilogram of excess fat increases the load on already fragile, under-mineralised bones. In adult HPP, stress fractures of the femur and metatarsal are characteristically bilateral and recurrent — excess weight dramatically accelerates their incidence. A 10 kg weight loss can meaningfully reduce fracture risk and pain burden in adults with HPP.
Conversely, in children with HPP, maintaining adequate weight and muscle mass is often the greater challenge — growth retardation and muscle weakness make normal weight achievement difficult.
The Vitamin B6 Warning — Critical for HPP Patients
This is the most counterintuitive and important nutritional fact about HPP. TNSALP normally cleaves pyridoxal-5-phosphate (PLP — the active form of vitamin B6) so it can enter cells. Without TNSALP, PLP accumulates extracellularly in the blood but cannot enter cells — so tissues are functionally B6-deficient despite high serum levels.
This leads to two critical rules:
- DO NOT supplement with high-dose vitamin B6 (pyridoxine) — the blood is already full of it; high-dose supplementation can cause peripheral neuropathy and worsens the pyridoxine toxicity risk
- Neonates and infants with HPP may have B6-responsive seizures — paradoxically, giving pyridoxine can stop seizures short-term, but this is a medical emergency, not a dietary intervention
Calcium and Phosphate: Not the Problem You Think
Unlike most bone diseases, HPP is not caused by calcium or phosphate deficiency. Mineralisation fails because PPi blocks crystal formation, not because raw materials are lacking. Therefore:
- High-dose calcium supplements are NOT indicated and may worsen hypercalcaemia (especially in infantile HPP)
- Vitamin D supplements are generally safe and appropriate (South Africa has good sun exposure, but indoor patients may be deficient), but monitor serum calcium if supplementing
- Dietary calcium from food (dairy, leafy greens) is fine — it's supplemental mega-doses that are problematic
- Phosphate intake from diet is normal
Weight Loss Diet Strategy for Adults with HPP
Calorie Approach: Moderate, Slow, Steady
Rapid weight loss is not the goal. Target 0.5 kg/week maximum. Crash diets risk muscle loss, which in HPP worsens the functional muscle weakness already present and reduces bone-protective load-bearing signals.
Protein: Protect Muscle and Bone
Muscle weakness is a documented feature of adult HPP (TNSALP is expressed in muscle too). High protein intake helps preserve muscle mass during weight loss:
- Target 1.2–1.6 g protein per kg bodyweight daily
- Eggs, chicken, fish, legumes, Greek yoghurt — all excellent SA-accessible options
- Amasi (maas) — traditional South African fermented milk; high in protein and probiotics, affordable across income groups
- Sardines and pilchards in tomato sauce — affordable, omega-3 rich, excellent protein
Bone-Supporting Nutrients (from food, not supplements)
| Nutrient | Role in HPP | SA Food Sources |
|---|---|---|
| Vitamin D (from sun/food) | Supports available calcium absorption; muscle function; immune support | Sunlight (15–20 min daily on arms), pilchards, eggs, fortified maas |
| Magnesium | Cofactor for bone crystal formation; muscle relaxation; reduces PPi build-up slightly | Pumpkin seeds, almonds, spinach, dark chocolate, legumes |
| Vitamin K2 | Activates osteocalcin; directs calcium into bone matrix | Fermented foods (mature cheese, natto if available), eggs |
| Omega-3 fatty acids | Reduces joint inflammation (pseudogout/chondrocalcinosis) | Pilchards, sardines, walnuts, flaxseed |
| Zinc | Required for collagen synthesis; bone matrix quality | Lean meat, legumes, pumpkin seeds, eggs |
Anti-Inflammatory Eating for Joint Protection
Chondrocalcinosis (calcium pyrophosphate crystal deposition) and pseudogout are common in adult HPP — joints become painful and inflamed. An anti-inflammatory diet helps manage flares:
- Rooibos tea — the South African anti-inflammatory hero; aspalathin and nothofagin reduce inflammatory cytokines; drink 3–5 cups daily
- Colourful vegetables: spinach, beetroot, sweet potato, peppers, tomatoes
- Berries, oranges, guava — vitamin C for collagen and anti-inflammation
- Turmeric with black pepper — curcumin reduces joint inflammation; add to stews, curries, eggs
- Olive oil or avocado oil for cooking
Foods to Limit
- Ultra-processed foods — high in phosphate additives (polyphosphates in processed meats, fast food); may worsen the phosphate-mineral imbalance
- Alcohol — toxic to bone cells (osteoblasts); reduces bone formation; absolute limit 1–2 units/occasion and not daily
- High-sugar foods — increase systemic inflammation; worsen joint disease
- Vitamin B6-fortified foods — check cereals and health bars; many are fortified to 100% RDA levels
Exercise with HPP: Protecting Fragile Bones
Safe Exercise Options
- Swimming and hydrotherapy — best option; no axial loading on bones; SA municipal pools, most towns have facilities; full cardiovascular and muscle workout with zero fracture risk
- Cycling (stationary bike) — low impact; reduces metatarsal stress compared to walking; good cardiovascular option
- Upper body resistance bands (seated) — strengthens arms and shoulders with no leg/foot loading
- Gentle yoga (chair-based or mat, no inversions) — improves flexibility and balance; reduces fall risk
- Walking on soft surfaces — if bone status permits (orthopaedist-confirmed); grass or soft track, supportive footwear; avoid hard pavement
Exercises to Avoid
- Running, jogging — high metatarsal and femoral stress fracture risk
- High-impact aerobics, jumping, skipping rope
- Heavy axial-loaded weights (squats, deadlifts with significant weight)
- Contact sports
- Long walking distances on hard surfaces without orthopaedic clearance
Asfotase Alfa (Strensiq) and Weight
Strensiq (asfotase alfa) is enzyme replacement therapy that can dramatically improve bone mineralisation, pain, and function in HPP. It is approved for paediatric-onset HPP. In South Africa, access is through the Alexion/AstraZeneca compassionate use programme or medical aid exceptional medication blocks — discuss with your metabolic physician. Patients on Strensiq often experience improved activity levels, which supports healthy weight management.
Finding HPP Support in South Africa
- Clinical geneticists: Available at academic hospitals — Red Cross War Memorial Children's Hospital (Cape Town), Steve Biko Academic Hospital (Pretoria), Charlotte Maxeke Johannesburg Academic Hospital, Inkosi Albert Luthuli Central Hospital (Durban)
- Dietitians: ADSA (adsa.org.za) for a registered dietitian with metabolic disease experience
- International HPP support: Soft Bones (softbones.org) — international HPP patient foundation with resources and research updates
Key Takeaways
- HPP is caused by ALPL gene mutations — deficient TNSALP leads to impaired bone mineralisation (accumulation of PPi), premature tooth loss, stress fractures, and muscle weakness
- Weight loss is important in adults because excess weight dramatically increases fracture risk on already fragile bones
- Do not take high-dose vitamin B6 supplements — this is the most critical dietary rule; check all supplements for pyridoxine content
- High-dose calcium supplements are not indicated; dietary calcium from food is fine
- Vitamin D, magnesium, K2, zinc, and omega-3s from food are beneficial
- Anti-inflammatory diet (rooibos, colourful vegetables, olive oil, omega-3) helps manage chondrocalcinosis/pseudogout
- Exercise: swimming and cycling preferred; avoid high-impact loading without orthopaedic clearance
- Asfotase alfa (Strensiq) can improve bone health and activity capacity — explore access via compassionate use
Connect with specialist support in South Africa
Find a registered dietitian with metabolic disease expertise at ADSA (adsa.org.za). For HPP-specific support and research updates, visit Soft Bones (softbones.org).
Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice. Hypophosphatasia requires diagnosis and management by a qualified metabolic physician and/or clinical geneticist. Do not alter medications, supplements, or exercise without consulting your healthcare team.
Sources: Whyte MP (2016) "Hypophosphatasia: Enzyme replacement therapy brings new opportunities and new challenges" Journal of Bone and Mineral Research; Mornet E (2018) "Hypophosphatasia" Metabolism; Kishnani PS et al. (2017) "Monitoring guidelines for infants and young children with hypophosphatasia treated with asfotase alfa" Molecular Genetics and Metabolism; Soft Bones Inc. (softbones.org).